Together, let’s use this great opportunity to put TB higher on the political agenda of the EU!

If enacted, the President’s budget would slash U.S. global TB funding to its lowest level since 2009.

WHO has revised its standard case definitions for TB and drug-resistant TB.

Open letters to Indian Prime Minister and Health Minister to support India’s refusal of any Trade-Related Aspects of Intellectual Property Rights (TRIPS)-Plus Provisions in Free-Trade Agreement negotiations with the European Union.

Tuberculosis costs the European Union EUR 750 million per year and the European region is home to the highest rates of multidrug-resistant TB in the world, accounting for nearly 20% of the global burden.

In communities that implement isoniazid preventive therapy, the incidence of new isoniazid-resistant cases per year will double in the next 40 years.

Issues like stigma, low socio-economic status and lack of education are significant barriers in early screening, diagnosis and treatment. And these delays perpetuate the transmission cycle.

Tuberculosis patients who swallow their anti-TB pills under the watchful gaze of health care workers fare just as well as patients trusted to self-medicate, according to a new meta-analysis.

Despite recent advances in TB diagnostics, current technologies suffer serious disadvantages.

A group of activists launched the Global Coalition of TB Activists (GCTA), a new network that aims to put communities affected by tuberculosis at the centre of decision making in the fight against TB.